Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  da Silva Voorham, Júlia M ^a   Rodenhuis Zybert, Izabela A ^a   Nuñez, Nilda Vanesa Ayala ^a   Colpitts, Tonya M ^b   van der Ende Metselaar, Heidi ^a   Fikrig, Erol ^b   Diamond, Michael S ^c   Wilschut, Jan ^a   Smit, Jolanda M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; PRECURSOR MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN ANTIBODY; VIRUS PROTEIN; ANTISERUM; E GLYCOPROTEIN, DENGUE VIRUS TYPE 2; E-GLYCOPROTEIN, DENGUE VIRUS TYPE 2; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; OPSONIN; PROTEIN PRECURSOR; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; IN VIVO STUDY; LETHALITY; MOUSE; NONHUMAN; OPSONIZATION; PROTEIN DOMAIN; VIRION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WEST NILE FLAVIVIRUS; ANIMAL; ANTIBODY DEPENDENT ENHANCEMENT; C57BL MOUSE; CELL LINE; CLASSIFICATION; DRUG ANTAGONISM; IMMUNOLOGY; PATHOGENICITY; PROTEIN BINDING; SEROTYPING; VIROLOGY; WEST NILE FEVER;

DENGUE VIRUS; FLAVIVIRUS; MUS; WEST NILE VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CELL LINE; DENGUE VIRUS; FURIN; IMMUNE SERA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; OPSONIN PROTEINS; PROTEIN BINDING; PROTEIN PRECURSORS; SEROTYPING; VIRAL ENVELOPE PROTEINS; VIRION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84858204844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029957     Document Type: Article

References (48)

1. WHO (2009) Dengue: guidelines for diagnosis, treatment, prevention and control- New edition Geneve.
2. Gubler DJKG, Markoff L, (2007) Fields Virology; Flaviviruses; In: Knipe DMHP, editors. Philadelphia Wolters Kluwer/Lippincott Williams & Wilkins pp. 1153-1252.
3. Halstead SB, Lan NT, Myint TT, Shwe TN, Nisalak A, et al. (2002) Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis 8: 1474-1479.
4. Kliks SC, Nimmanitya S, Nisalak A, Burke DS, (1988) Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38: 411-419.
5. Halstead SB, O'Rourke EJ, (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
6. Halstead SB, (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
7. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, et al. (2001) Immunopathogenesis of dengue virus infection. J Biomed Sci 8: 377-388.
8. Mukhopadhyay S, Kuhn RJ, Rossmann MG, (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3: 13-22.
9. Lorenz IC, Allison SL, Heinz FX, Helenius A, (2002) Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol 76: 5480-5491.
10. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC, (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375: 291-298.
11. Modis Y, Ogata S, Clements D, Harrison SC, (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100: 6986-6991.
12. Zhang Y, Zhang W, Ogata S, Clements D, Strauss JH, et al. (2004) Conformational changes of the flavivirus E glycoprotein. Structure 12: 1607-1618.
13. Modis Y, Ogata S, Clements D, Harrison SC, (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427: 313-319.
14. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, et al. (2004) Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. Embo J 23: 728-738 Epub 2004 Feb 2012.
15. Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX, (2001) Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 75: 4268-4275.
16. Crill WD, Roehrig JT, (2001) Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75: 7769-7773.
17. Chu JJ, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, et al. (2005) Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol 86: 405-412.
18. Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, et al. (2009) Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. Embo J 28: 3269-3276.
19. Junjhon J, Edwards TJ, Utaipat U, Bowman VD, Holdaway HA, et al. (2010) Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J Virol 84: 8353-8358.
20. Zhang Y, Kaufmann B, Chipman PR, Kuhn RJ, Rossmann MG, (2007) Structure of immature West Nile virus. J Virol 81: 6141-6145.
21. Zybert IA, van der Ende-Metselaar H, Wilschut J, Smit JM, (2008) Functional importance of dengue virus maturation: infectious properties of immature virions. J Gen Virol 89: 3047-3051.
22. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, et al. (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108: 717-725.
23. Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, et al. (2003) Structures of immature flavivirus particles. Embo J 22: 2604-2613.
24. Junjhon J, Lausumpao M, Supasa S, Noisakran S, Songjaeng A, et al. (2008) Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction. J Virol 82: 10776-10791.
25. Elshuber S, Allison SL, Heinz FX, Mandl CW, (2003) Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J Gen Virol 84: 183-191.
26. Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der Ende-Metselaar H, Lei HY, et al. (2010) Immature dengue virus: a veiled pathogen? PLoS Pathog 6: e1000718.
27. Nelson S, Jost CA, Xu Q, Ess J, Martin JE, et al. (2008) Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog 4: e1000060.
28. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, et al. (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328: 745-748.
29. Zheng A, Umashankar M, Kielian M, (2010) In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS 6: e1001157.
30. Rodenhuis-Zybert IA, Moesker B, da Silva Voorham JM, van der Ende-Metselaar H, Diamond MS, et al. Enhancing effect of a fusion-loop antibody on the infectious properties of immature flavivirus particles. J Virol.
31. Stiasny K, Kiermayr S, Holzmann H, Heinz FX, (2006) Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol 80: 9557-9568.
32. Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, et al. (2007) Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol 81: 11828-11839.
33. Crill WD, Hughes HR, Delorey MJ, Chang GJ, (2009) Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One 4: e4991.
34. Throsby M, Geuijen C, Goudsmit J, Bakker AQ, Korimbocus J, et al. (2006) Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J Virol 80: 6982-6992.
35. Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, et al. (2010) Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol 84: 9227-9239.
36. Sung SS, (1985) Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions. J Immunol 135: 1981-1986.
37. Ochiai H, Kurokawa M, Hayashi K, Niwayama S, (1988) Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J Virol 62: 20-26.
38. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, et al. (2007) Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81: 12019-12028.
39. Garten W, Hallenberger S, Ortmann D, Schafer W, Vey M, et al. (1994) Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie 76: 217-225.
40. Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, et al. (2010) Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J 7: 28.
41. Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, et al. (2010) The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8: 271-283.
42. Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, et al. (2007) The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1: 135-145.
43. Bai F, Town T, Qian F, Wang P, Kamanaka M, et al. (2009) IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog 5: e1000610.
44. Moesker B, Rodenhuis-Zybert IA, Meijerhof T, Wilschut J, Smit JM, (2010) Characterization of the functional requirements of West Nile virus membrane fusion. J Gen Virol 91: 389-393 Epub 2009 Oct 2014.
45. Oliphant T, Nybakken GE, Engle M, Xu Q, Nelson CA, et al. (2006) Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol 80: 12149-12159.
46. Heinz FXSK, Püschner-Auer G, Holzmann H, Allison SL, Mandl CW, Kunz C, (1994) Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 198: 109-117.
47. Guirakhoo FBR, Roehrig JT, (1992) The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology 191: 921-931.
48. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E, (2000) Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74: 7814-7823.